Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens.

Samples LS, Rendi MH, Frederick PD, Allison KH, Nelson HD, Morgan TR, Weaver DL, Elmore JG.

Breast. 2017 Aug;34:34-43. doi: 10.1016/j.breast.2017.04.004. Epub 2017 May 3.

PMID:
28475933
2.

Is the outcome at surgery different when flat epithelial atypia and lobular neoplasia are found in association at biopsy?

El Khoury M, Sanchez LM, Lalonde L, Trop I, David J, Mesurolle B.

Br J Radiol. 2017 Apr;90(1072):20160750. doi: 10.1259/bjr.20160750. Epub 2017 Mar 3.

PMID:
28118035
3.

Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.

Geyer FC, Berman SH, MarchiĆ² C, Burke KA, Guerini-Rocco E, Piscuoglio S, Ng CK, Pareja F, Wen HY, Hodi Z, Schnitt SJ, Rakha EA, Ellis IO, Norton L, Weigelt B, Reis-Filho JS.

Mod Pathol. 2017 Jan;30(1):69-84. doi: 10.1038/modpathol.2016.161. Epub 2016 Oct 7.

4.

Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.

Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, Ghosh K, Radisky DC, Hartmann LC, Degnim AC.

Cancer. 2015 May 15;121(10):1548-55. doi: 10.1002/cncr.29243. Epub 2015 Jan 13.

5.

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.

Hilton HN, Doan TB, Graham JD, Oakes SR, Silvestri A, Santucci N, Kantimm S, Huschtscha LI, Ormandy CJ, Funder JW, Simpson ER, Kuczek ES, Leedman PJ, Tilley WD, Fuller PJ, Muscat GE, Clarke CL.

Oncotarget. 2014 Sep 30;5(18):8651-64.

7.

Lobular neoplasia: frequency and association with other breast lesions.

Gomes DS, Balabram D, Porto SS, Gobbi H.

Diagn Pathol. 2011 Aug 9;6:74. doi: 10.1186/1746-1596-6-74.

9.

The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.

Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1053-60. doi: 10.1007/s00432-011-0979-z. Epub 2011 Apr 17.

10.

Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.

Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM.

Breast Cancer Res. 2010;12(4):R61. doi: 10.1186/bcr2624. Epub 2010 Aug 6.

11.

Clinician's guide to imaging and pathologic findings in benign breast disease.

Neal L, Tortorelli CL, Nassar A.

Mayo Clin Proc. 2010 Mar;85(3):274-9. doi: 10.4065/mcp.2009.0656. Review.

12.

The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density.

Lewis TJ, Dupont WD, Egan KM, Jones CD, Disher AC, Riddle WR, Fair AM.

J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):17-25. doi: 10.1353/hpu.0.0238.

13.

A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE.

Cancer Causes Control. 2010 Jun;21(6):821-8. doi: 10.1007/s10552-010-9508-7. Epub 2010 Jan 19.

Supplemental Content

Support Center